Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PANTHER: Upfront Pazopanib in Metastatic Clear Cell Renal Cancer
2009-016675-29Phase 2Completed
- Sponsor
- Queen Mary University of London
- Start
- Mar 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of pazopanib in clear cell renal cell carcinoma (ccRCC), sponsored by Queen Mary University of London. Primary endpoint: Clinical benefit from pre-operative pazopanib. Started Mar 2010; status: completed.
02
Drugs
pazopanib
03
Conditions
clear cell renal cell carcinoma (ccRCC)
Beyond the preview
Go deeper on 2009-016675-29.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-016675-29.